+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Animal Vaccines Market Size, Share & Trends Analysis Report by Product (Attenuated Live Vaccines, Recombinant Vaccines), by Animal Type (Livestock, Companion), by Route Of Administration, by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • February 2022
  • Region: Global
  • Grand View Research
  • ID: 4452075
The global animal vaccines market size is expected to reach USD 26.12 billion by 2030. The market is expected to expand at a CAGR of 9.3% from 2022 to 2030. The growing incidence of food-borne zoonotic diseases and increasing animal husbandry are boosting the demand for vaccines. Certain transmissible diseases such as bird flu and tuberculosis in invertebrate animals can be transferred directly or indirectly to humans. If consumers eat worms via undercooked fish, they can get contaminated with anisakiasis, a human zoonotic infection caused by some species of nematodes.



The increasing outbreaks of cattle disease and the ever-expanding livestock population are the prime factors for the wide acceptance of the ruminants especially cattle vaccines globally. Moreover, rising pet ownership and increasing awareness regarding the health of companion animals are propelling the market growth. Moreover, the increasing number of R&D investments initiated by the companies is one of the key growth factors. Competition in the market is expected to be high during the forecast period. The market is highly fragmented owing to the presence of several small and large players. This results in high competition among small players to sustain their position in the market.

Moreover, companies are increasingly adopting strategies, such as mergers & acquisitions, geographic expansion, and the launch of new products, to grow in the market. For instance, in December 2020, Elanco acquired exclusive global rights from Kindred Biosciences to its monoclonal antibody for Canine Parvovirus (CPV) called KIND-030. This strengthened the company’s overall vaccine and therapeutics portfolios. Moreover, in September 2020, Ceva enhanced its production capacity at its French facility for bacterial autogenous vaccines. This is expected to support its growth strategy.

Animal Vaccines Market Report Highlights

  • Based on product, attenuated live vaccines emerged as the largest segment in 2021 as a result of the benefits such as improved effectiveness and enhanced long-term prevention. The recombinant vaccine is expected to witness considerable growth during the forecast period. These vaccine formulations can avoid the need for adjuvants, increase the viability of the vaccine, and improve stability
  • The livestock animal type segment dominated the market in 2021. According to Elsevier, Inc., as of February 2020, in Bangladesh, the prevalence of foot and mouth diseases in cattle was 24.71%
  • By route of administration, the intranasal segment is expected to register the fastest growth rate of 10.0% over the projected period owing to its growing popularity
  • North America dominated the market in 2021. Constantly rising awareness regarding livestock health and increasing commercialization of livestock products are factors expected to drive the market in the region during the forecast period
  • In Asia Pacific, the market is projected to witness swift growth during the forecast period owing to the speedy adoption of animal vaccines for quality food products and better animal health
  • Market players are opting for numerous strategies such as partnerships and new product launches. For instance, in October 2021, CZ VACCINES launched a new conjunctival vaccine called B19 CZV Ocular, thus adding a new vaccine to its range of brucellosis vaccines


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Animal type
1.1.3 Route of Administration
1.1.4 Regional Scope
1.1.5 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Latin America
1.3.5.5 Data for primary interviews in Middle East and Africa
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Animal Vaccines Market Outlook, 2017 - 2030 (USD Million)
2.2 Segment Outlook
2.3 Animal Vaccines Market Summary, 2021
Chapter 3 Animal Vaccines Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory Framework
3.4 Animal Vaccines Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Rising livestock population and pet ownership
3.4.1.2 Increasing disease outbreaks
3.4.1.3 Rising R&D and manufacturing procedural advancements
3.4.1.4 Growing demand for animal-derived food products
3.4.1.5 regulatory mandates
3.4.2 Market restraint analysis
3.4.2.1 Government intervention
3.4.2.2 Short product exclusivity period
3.4.2.3 high storage cost of vaccines
3.5 Animal Vaccines Market Analysis Tools: Porters
3.5.1 Supplier Power: Low
3.5.2 Buyer Power: moderate
3.5.3 Threat Of Substitutes: Low
3.5.4 Threat Of New Entrants: Moderate
3.5.5 Competitive Rivalry: High
3.6 PESTEL Analysis
3.6.1 Political landscape
3.6.2 Economic landscape
3.6.3 Social landscape
3.6.4 Technology landscape
3.6.5 Legal landscape
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Mergers & Acquisitions
3.7.2 Product Launch
3.7.3 Expansion
Chapter 4 Animal Vaccines Market: Competitive Analysis
4.1 Market Participation Categorization
4.2 Public Companies
4.2.1 Company market share/position analysis
4.2.2 Competitive Dashboard Analysis
4.3 Private Companies
4.3.1 List of key emerging companies
Chapter 5 Animal Vaccines Market: COVID Impact Analysis
5.1 Impact of Disease Outbreak on The Market
Chapter 6 Animal Vaccines Market: Product Estimates & Trend Analysis
6.1 Product Market Share Analysis, 2021 & 2030
6.2 Product Dashboard
6.3 Global Animal Vaccines Market, By Product, 2017 to 2030
6.3.1 Attenuated live vaccines
6.3.1.1 Attenuated live vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
6.3.2 Inactivated vaccines
6.3.2.1 Inactivated vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
6.3.3 Subunit vaccines
6.3.3.1 Subunit vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
6.3.4 DNA vaccines
6.3.4.1 DNA vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
6.3.5 Recombinant vaccines
6.3.5.1 Recombinant vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 7 Animal Vaccines Market: Animal type Estimates & Trend Analysis
7.1 Animal Type Market Share Analysis, 2021 & 2030
7.2 Animal Type Dashboard
7.2.1 Livestock
7.2.1.1 Livestock Market by animal type
7.2.1.2 Poultry
7.2.1.2.1 Poultry market estimates and forecasts, 2017 - 2030 (USD Million)
7.2.1.3 Aqua
7.2.1.3.1 Aqua market estimates and forecasts, 2017 - 2030 (USD Million)
7.2.1.4 Ruminants
7.2.1.4.1 Ruminants market estimates and forecasts, 2017 - 2030 (USD Million)
7.2.1.5 Swine
7.2.1.5.1 Swine market estimates and forecasts, 2017 - 2030 (USD Million)
7.2.2 Companion
7.2.2.1 Companion Market by animal type
7.2.2.2 Canine
7.2.2.2.1 Canine market estimates and forecasts, 2017 - 2030 (USD Million)
7.2.2.3 Feline
7.2.2.3.1 Feline market estimates and forecasts, 2017 - 2030 (USD Million)
7.2.2.4 Others
7.2.2.4.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 8 Animal Vaccines Market: Route of Administration Estimates & Trend Analysis
8.1 Route of Administration Market Share Analysis, 2021 & 2030
8.2 Route of Administration Dashboard
8.3 Global Animal Vaccines Market, By Route of Administration, 2017 to 2030
8.3.1 Subcutaneous
8.3.1.1 Subcutaneous market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.2 Intramuscular
8.3.2.1 Intramuscular market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.3 Intranasal
8.3.3.1 Intranasal market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 9 Animal Vaccines Market: Regional Estimates & Trend Analysis, by, Product, Animal Type, Route of Administration
9.1 Regional Market Snapshot
9.2 North America
9.2.1 North America Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. Animal Vaccines market estimates and forecasts, 2017 - 2030(USD Million)
9.2.3 Canada
9.2.3.1 Canada Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.3 Europe
9.3.1 Europe Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.3.2 U.K.
9.3.2.1 U.K. Animal Vaccines market estimates and forecasts, 2017 - 2030(USD Million)
9.3.3 Germany
9.3.3.1 Germany Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.3.4 France
9.3.4.1 France Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.3.5 Italy
9.3.5.1 Italy Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.3.6 Spain
9.3.6.1 Spain Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.4.2 Japan
9.4.2.1 Japan Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.4.3 China
9.4.3.1 China Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.4.4 India
9.4.4.1 India Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.4.5 South Korea
9.4.5.1 South Korea Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.5 Latin America
9.5.1 Latin America Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.5.4 Argentina
9.5.4.1 Argentina Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.6 MEA
9.6.1 MEA Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Saudi Arabia Animal Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 10 Company Profiles
10.1 Merck & Co., Inc.
10.1.1 Company overview
10.1.2 Financial performance
10.1.3 Product benchmarking
10.1.4 Strategic initiatives
10.2 Zoetis
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.2.4 Strategic initiatives
10.3 Boehringer Ingelheim International GmbH
10.3.1 Company overview
10.3.2 Financial performance
10.3.3 Product benchmarking
10.3.4 Strategic initiatives
10.4 Virbac
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking
10.4.4 Strategic initiatives
10.5 Biogénesis Bagó
10.5.1 Company overview
10.5.2 FINANCIAL PERFORMANCE
10.5.3 Product benchmarking
10.5.4 Strategic initiatives
10.6 Indian Immunologicals Ltd.
10.6.1 Company overview
10.6.2 Product benchmarking
10.6.3 Strategic initiatives
10.7 Elanco
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic initiatives
10.8 Ceva
10.8.1 Company overview
10.8.2 FINANCIAL PERFORMANCE
10.8.3 R&D Investment
10.8.4 Product benchmarking
10.8.5 Strategic initiatives
10.9 Phibro Animal Health Corporation
10.9.1 Company overview
10.9.2 Financial performance
10.9.3 Product benchmarking
10.9.4 Strategic initiatives
10.10 Neogen Corporation
10.10.1 Company overview
10.10.2 Financial performance
10.10.3 Product benchmarking
10.10.4 Strategic initiatives
10.11 Intas Pharmaceuticals Ltd.
10.11.1 Company overview
10.11.2 Financial performance
10.11.3 Product benchmarking
10.11.4 Strategic initiatives
10.12 Ourofino Saúde Animal
10.12.1 Company overview
10.12.2 Financial performance
10.12.3 Product benchmarking
10.12.4 Strategic initiatives
List of Tables
Table 1 North America animal vaccines market, by product, 2017-2030 (USD Million)
Table 2 North America animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 3 North America animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 3 U.S. animal vaccines market, by product, 2017-2030 (USD Million)
Table 4 U.S. animal vaccines market, by animal type, 2017-2030 (USD million)
Table 5 U.S. animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 6 Canada animal vaccines market, by product, 2017-2030 (USD Million)
Table 7 Canada animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 8 Canada animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 9 Europe animal vaccines market, by product, 2017-2030 (USD Million)
Table 10 Europe animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 11 Europe animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 12 U.K. animal vaccines market, by product, 2017-2030 (USD Million)
Table 13 U.K. animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 14 U.K. animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 15 Germany animal vaccines market, by product, 2017-2030 (USD Million)
Table 16 Germany animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 17 Germany animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 18 France animal vaccines market, by product, 2017-2030 (USD Million)
Table 19 France animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 20 France animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 21 Italy animal vaccines market, by product, 2017-2030 (USD Million)
Table 22 Italy animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 23 Italy animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 24 Spain animal vaccines market, by product, 2017-2030 (USD Million)
Table 25 Spain animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 26 Spain animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 27 Asia Pacific animal vaccines market, by product, 2017-2030 (USD Million)
Table 28 Asia Pacific animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 30 Asia Pacific animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 31 Japan animal vaccines market, by product, 2017-2030 (USD Million)
Table 32 Japan animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 33 Japan animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 34 China animal vaccines market, by product, 2017-2030 (USD Million)
Table 35 China animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 36 China animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 37 India animal vaccines market, by product, 2017-2030 (USD Million)
Table 38 India animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 39 India animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 40 South Korea animal vaccines market, by product, 2017-2030 (USD Million)
Table 41 South Korea animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 42 South Korea animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 43 Latin America animal vaccines market, by product, 2017-2030 (USD Million)
Table 44 Latin America animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 45 Latin America animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 46 Brazil animal vaccines market, by product, 2017-2030 (USD Million)
Table 47 Brazil animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 48 Brazil animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 49 Mexico animal vaccines market, by product, 2017-2030 (USD Million)
Table 50 Mexico animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 51 Mexico animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 52 Argentina animal vaccines market, by product, 2017-2030 (USD Million)
Table 53 Argentina animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 54 Argentina animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 55 MEA animal vaccines market, by product, 2017-2030 (USD Million)
Table 56 MEA animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 57 MEA animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 58 South Africa animal vaccines market, by product, 2017-2030 (USD Million)
Table 59 South Africa animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 60 South Africa animal vaccines market, by route of administration, 2017-2030 (USD Million)
Table 61 Saudi Arabia animal vaccines market, by product, 2017-2030 (USD Million)
Table 62 Saudi Arabia animal vaccines market, by animal type, 2017-2030 (USD Million)
Table 63 Saudi Arabia animal vaccines market, by route of administration, 2017-2030 (USD Million)
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Primary interviews in North America
Fig. 6 Primary interviews in Europe
Fig. 7 Primary interviews in Asia Pacific
Fig. 8 Primary interviews in Latin America
Fig. 9 Primary interviews in Middle East and Africa
Fig. 10 Market research approaches
Fig. 11 Value-chain-based sizing & forecasting
Fig. 12 QFD modeling for market share assessment
Fig. 13 Market formulation & validation
Fig. 14 Commodity flow analysis
Fig. 15 Animal Vaccines market revenue, 2017-2030 (USD Million)
Fig. 16 Animal vaccines market snapshot (USD Million)
Fig. 17 Penetration & growth prospect mapping
Fig. 18 Animal vaccines market dynamics
Fig. 19 Animal vaccines market driver impact
Fig. 20 Estimated pet population in the U.S., 2015-2019 (million)
Fig. 21 Animal Vaccines market restraint impact
Fig. 22 Strategy mapping
Fig. 23 Market participant categorization
Fig. 24 Company market position analysis
Fig. 25 Competitive dashboard analysis
Fig. 26 Animal vaccines market: Product movement analysis
Fig. 27 Animal vaccines market product dashboard
Fig. 28 Animal vaccines market by product
Fig. 29 Global attenuated live vaccines market, 2017-2030 (USD Million)
Fig. 30 Global inactivated vaccines market, 2017-2030 (USD Million)
Fig. 31 Global subunit vaccines market, 2017-2030 (USD Million)
Fig. 32 Global DNA vaccines market, 2017-2030 (USD Million)
Fig. 33 Global recombinant vaccines market, 2017-2030 (USD Million)
Fig. 34 Animal vaccines market: Animal type movement analysis
Fig. 35 Animal vaccines animal type dashboard
Fig. 36 Global livestock market, 2017-2030 (USD Million)
Fig. 37 Global poultry market, 2017-2030 (USD Million)
Fig. 38 Global aqua market, 2017-2030 (USD Million)
Fig. 39 Global ruminants market, 2017-2030 (USD Million)
Fig. 40 Global swine market, 2017-2030 (USD Million)
Fig. 41 Global companion market, 2017-2030 (USD Million)
Fig. 42 Global canine market, 2017-2030 (USD Million)
Fig. 43 Global feline market, 2017-2030 (USD Million)
Fig. 44 Global others market, 2017-2030 (USD Million)
Fig. 45 Animal vaccines market: Route of administration movement analysis
Fig. 46 Animal vaccines Route of administration dashboard
Fig. 47 Global intramuscular market, 2017-2030 (USD Million)
Fig. 48 Global subcutaneous market, 2017-2030 (USD Million)
Fig. 49 Global intranasal market, 2017-2030 (USD Million)
Fig. 50 Regional market place: Key takeaways
Fig. 51 Regional outlook, 2021 & 2030
Fig. 52 North America Animal Vaccines market, 2017-2030 (USD Million)
Fig. 53 U.S. Animal Vaccines market, 2017-2030 (USD Million)
Fig. 54 Canada Animal Vaccines market, 2017-2030 (USD Million)
Fig. 55 Europe Animal Vaccines market, 2017-2030 (USD Million)
Fig. 56 U.K. Animal Vaccines market, 2017-2030 (USD Million)
Fig. 57 Germany Animal Vaccines market, 2017-2030 (USD Million)
Fig. 58 France Animal Vaccines market, 2017-2030 (USD Million)
Fig. 59 Italy Animal Vaccines market, 2017-2030 (USD Million)
Fig. 60 Spain Animal Vaccines market, 2017-2030 (USD Million)
Fig. 61 Asia Pacific Animal Vaccines market, 2017-2030 (USD Million)
Fig. 62 Japan Animal Vaccines market, 2017-2030 (USD Million)
Fig. 63 China Animal Vaccines market, 2017-2030 (USD Million)
Fig. 64 India Animal Vaccines market, 2017-2030 (USD Million)
Fig. 65 South Korea Animal Vaccines market, 2017-2030 (USD Million)
Fig. 66 Latin America Animal Vaccines market, 2017-2030 (USD Million)
Fig. 67 Brazil Animal Vaccines market, 2017-2030 (USD Million)
Fig. 68 Mexico Animal Vaccines market, 2017-2030 (USD Million)
Fig. 69 Argentina Animal Vaccines market, 2017-2030 (USD Million)
Fig. 70 MEA Animal Vaccines market, 2017-2030 (USD Million)
Fig. 71 South Africa Animal Vaccines market, 2017-2030 (USD Million)
Fig. 72 Saudi Arabia Animal Vaccines market, 2017-2030 (USD Million)

Companies Mentioned

  • Merck & Co., Inc.
  • Zoetis
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Biogénesis Bagó
  • Indian Immunologicals Ltd.
  • Elanco
  • Ceva
  • Phibro Animal Health Corporation
  • Neogen Corporation
  • Intas Pharmaceuticals Ltd.
  • Ourofino Saúde Animal

Methodology

Loading
LOADING...

Table Information